AF
SRPT icon

Advisornet Financial’s Sarepta Therapeutics SRPT Stock Holding History

Advisornet Financial’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$22 – 2362
2025
Q4 		$22 Sell
1
-3
-75% -$63 ﹤0.01% 2217
2025
Q3 		$77 Buy
4
+1
+33% +$18 ﹤0.01% 2199
2025
Q2 		$51 Sell
3
-3
-50% -$128 ﹤0.01% 2198
2025
Q1 		$383 Buy
6
+1
+20% +$105 ﹤0.01% 2009
2024
Q4 		$608 Sell
5
-3
-38% -$368 ﹤0.01% 1737
2024
Q3 		$999 Buy
8
+3
+60% +$415 ﹤0.01% 1943
2024
Q2 		$790 Hold
5
– – ﹤0.01% 1865
2024
Q1 		$647 Sell
5
-1
-17% -$122 ﹤0.01% 1855
2023
Q4 		$579 Buy
6
+4
+200% +$384 ﹤0.01% 2059
2023
Q3 		$242 Buy
2
+1
+100% +$113 ﹤0.01% 2114
2023
Q2 		$115 Sell
1
-1
-50% -$129 ﹤0.01% 2261
2023
Q1 		$276 Buy
2
+1
+100% +$130 ﹤0.01% 2199
2022
Q4 		$130 Buy
+1
New +$116 ﹤0.01% 2264
2020
Q1 		– Sell
-100
Closed -$13K – 1924
2019
Q4 		$13K Buy
+100
New +$10.1K ﹤0.01% 1321

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisornet Financial's SRPT Position: Q1 2026 in Review

Advisornet Financial sold out of Sarepta Therapeutics (SRPT) in Q1 2026, closing a stake of 1 share — an estimated $22 sold.

Advisornet Financial first reported a position in SRPT in Q4 2019 and held it in 14 quarters. The position peaked at $13K in Q4 2019. 345 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Advisornet Financial reported no remaining Sarepta Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Advisornet Financial sold 1 Sarepta Therapeutics share in Q1 2026, an estimated $22.
  • Advisornet Financial first reported a position in Sarepta Therapeutics in Q4 2019 and held it in 14 quarters.
  • Advisornet Financial's Sarepta Therapeutics position peaked at $13K in Q4 2019.
  • 345 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.